Bioengineer.org

Exploring Lymphovenous Bypass as a Promising Surgical Approach for Alzheimer’s Disease

Researchers have adapted lymphovenous bypass, a microsurgical technique that reroutes lymphatic fluid into the venous system, as a potential treatment for Alzheimer’s disease. In a Phase I pilot study of 20 patients, the procedure reduced cerebral amyloid‑β levels by roughly 30% and improved standard cognitive assessments by 15% over six months, with no serious adverse events reported. The approach targets impaired glymphatic clearance, addressing neuroinflammation and protein aggregation at the root of disease progression. Findings suggest surgical modulation of brain lymphatics could complement existing drug therapies.